MIM Software Inc. Announces Updates to MIM Encore™

Tuesday, May 23, 2017 General News
Email Print This Page Comment
Font : A-A+

CLEVELAND, May 23, 2017 /PRNewswire/ -- MIM Software Inc. announced today significant updates to its MIM Encore solution.

MIM

Encore is a vendor-neutral application for viewing PET/CT, SPECT/CT PET/MRI, and general nuclear medicine images. Physicians and technologists can streamline the nuclear medicine workflow by viewing and processing images in tandem using this single platform
solution.

The update includes various enhancements and new features such as enhanced display management tools for quick swapping of n number of follow-up exams, dedicated reports for tracking each patient's findings for referrers, a new dictation software integration focused on transferring findings statistics to reports, new contouring tools, and much more.

Some of the institutions currently utilizing MIM Encore clinically include Beth Israel Deaconess Medical Center, Hong Kong Sanatorium & Hospital, Mayo Clinic, Peter MacCallum Cancer Centre, Stanford Health Care, UAB Hospital, and the University of Virginia Health System.

MIM Software will be demonstrating MIM Encore at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting June 10-13 in Denver, CO. 

About MIM Software Inc.

MIM Software Inc. provides practical imaging solutions in the fields of radiation oncology, radiology, nuclear medicine, neuroimaging, and cardiac imaging. MIM offers solutions for PC and Mac® workstations as well as mobile iOS and cloud-based platforms. MIM is a privately held company that sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies.

For more information, visit www.mimsoftware.com. 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mim-software-inc-announces-updates-to-mim-encore-300462320.html

SOURCE MIM Software Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook